Arbutus Biopharma
Earnings Surprise
Analysts estimated ABUS earnings of $-0.04 per share this quarter (Q4). ABUS's actual earnings were $-0.02 per share.
ABUS EPS surprise of 43.98%Analysts estimated ABUS earnings of $-0.03 per share this quarter (Q3). ABUS's actual earnings were $-0.04 per share.
ABUS EPS surprise of -26.58%Analysts estimated ABUS earnings of $-0.05 per share this quarter (Q2). ABUS's actual earnings were $0.01 per share.
ABUS EPS surprise of 120.62%Analysts estimated ABUS earnings of $-0.11 per share this quarter (Q1). ABUS's actual earnings were $-0.13 per share.
ABUS EPS surprise of -23.22%Analysts estimated ABUS earnings of $-0.08 per share this quarter (Q4). ABUS's actual earnings were $-0.07 per share.
ABUS EPS surprise of 14.22%Analysts estimated ABUS earnings of $-0.10 per share this quarter (Q3). ABUS's actual earnings were $-0.09 per share.
ABUS EPS surprise of 6.74%Analysts estimated ABUS earnings of $-0.10 per share this quarter (Q2). ABUS's actual earnings were $-0.11 per share.
ABUS EPS surprise of -11.45%Analysts estimated ABUS earnings of $-0.11 per share this quarter (Q1). ABUS's actual earnings were $-0.10 per share.
ABUS EPS surprise of 10.87%Analysts estimated ABUS earnings of $-0.12 per share this quarter (Q4). ABUS's actual earnings were $-0.12 per share.
ABUS EPS surprise of -0.33%Analysts estimated ABUS earnings of $-0.12 per share this quarter (Q4). ABUS's actual earnings were $-0.12 per share.
ABUS EPS surprise of -0.33%